{"id":441789,"date":"2021-02-23T08:03:45","date_gmt":"2021-02-23T13:03:45","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=441789"},"modified":"2021-02-23T08:03:45","modified_gmt":"2021-02-23T13:03:45","slug":"gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021\/","title":{"rendered":"Gracell Biotechnologies to Report Fourth Quarter and Fiscal 2020 Financial Results on Tuesday, March 9, 2021"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>SUZHOU and <span class=\"xn-location\">SHANGHAI, China<\/span>, <span class=\"xn-chron\">Feb. 23, 2021<\/span> \/PRNewswire\/ &#8212; Gracell Biotechnologies Inc. (NASDAQ: GRCL) (&#8220;Gracell&#8221;), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies, today announced that it plans to release financial results for the fourth quarter and year ended <span class=\"xn-chron\">December 31, 2020<\/span> after the close of the U.S. financial markets on <span class=\"xn-chron\">Tuesday, March 9<\/span>. Gracell&#8217;s management team plans to host a corresponding conference call beginning at <span class=\"xn-chron\">8:00 a.m. Eastern Time on Wednesday<\/span>, March 10, to discuss the financial results and recent business developments. A replay of the webcast will be available on <a target=\"_blank\" href=\"https:\/\/ir.gracellbio.com\/\" rel=\"nofollow noopener noreferrer\"><u>ir.gracellbio.com<\/u><\/a>shortly after the conclusion of the event for 90 days.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1358687\/gracell_logo_Logo.html\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1358687\/gracell_logo_Logo.jpg\" title=\"(PRNewsfoto\/Gracell)\" alt=\"(PRNewsfoto\/Gracell)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\n        <b>Conference call and webcast details:<br \/><\/b><br \/>\n        <i><br \/>\n          <span class=\"xn-chron\">Wednesday, March 10, 2021<\/span> @ <span class=\"xn-chron\">8:00am ET<\/span><br \/><\/i>Investor domestic dial-in: 877-407-0784<br \/>Investor international dial-in: +1 201-689-8560<br \/>Conference ID: 13716516<br \/>Live webcast link: <a target=\"_blank\" href=\"https:\/\/ir.gracellbio.com\/news-events\/events-and-presentations\" rel=\"nofollow noopener noreferrer\">https:\/\/ir.gracellbio.com\/news-events\/events-and-presentations<\/a><\/p>\n<p>\n        <b>About Gracell <\/b>\n      <\/p>\n<p>Gracell Biotechnologies Inc. (&#8220;Gracell&#8221;) is a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies. Leveraging its pioneering FasTCAR and TruUCAR technology platforms, Gracell is developing a rich clinical-stage pipeline of multiple autologous and allogeneic product candidates with the potential to overcome major industry challenges that persist with conventional CAR-T therapies, including lengthy manufacturing time, suboptimal production quality, high therapy cost and lack of effective CAR-T therapies for solid tumors.<\/p>\n<p>\n        <b>Media contact<\/b>\n      <\/p>\n<p>\n        <b><br \/>\n          <span class=\"xn-person\">Linc He<\/span><br \/>\n        <\/b><br \/>\n        <br \/>\n        <a target=\"_blank\" href=\"mailto:Linc.he@gracellbio.com\" rel=\"nofollow noopener noreferrer\">Linc.he@gracellbio.com<\/a><br \/>\n        <br \/>\n        <span id=\"spanHghlt60bf\">+86 021 64031522<\/span><br \/>\n        \n      <\/p>\n<p>\n        <b>Investor contact<br \/><\/b><br \/>\n        <b><br \/>\n          <span class=\"xn-person\">Gracie Tong<\/span><br \/>\n          <br \/>\n        <\/b><br \/>\n        <a target=\"_blank\" href=\"mailto:Gracie.tong@gracellbio.com\" rel=\"nofollow noopener noreferrer\">Gracie.tong@gracellbio.com<\/a>\n      <\/p>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=CN87671&amp;sd=2021-02-23\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021-301232997.html\">http:\/\/www.prnewswire.com\/news-releases\/gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021-301232997.html<\/a><\/p>\n<p>SOURCE  Gracell Biotechnologies<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=CN87671&amp;Transmission_Id=202102230800PR_NEWS_USPR_____CN87671&amp;DateId=20210223\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire SUZHOU and SHANGHAI, China, Feb. 23, 2021 \/PRNewswire\/ &#8212; Gracell Biotechnologies Inc. (NASDAQ: GRCL) (&#8220;Gracell&#8221;), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies, today announced that it plans to release financial results for the fourth quarter and year ended December 31, 2020 after the close of the U.S. financial markets on Tuesday, March 9. Gracell&#8217;s management team plans to host a corresponding conference call beginning at 8:00 a.m. Eastern Time on Wednesday, March 10, to discuss the financial results and recent business developments. A replay of the webcast will be available on ir.gracellbio.comshortly after the conclusion of the event for 90 days. Conference call and webcast details: Wednesday, March 10, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Gracell Biotechnologies to Report Fourth Quarter and Fiscal 2020 Financial Results on Tuesday, March 9, 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-441789","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Gracell Biotechnologies to Report Fourth Quarter and Fiscal 2020 Financial Results on Tuesday, March 9, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gracell Biotechnologies to Report Fourth Quarter and Fiscal 2020 Financial Results on Tuesday, March 9, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire SUZHOU and SHANGHAI, China, Feb. 23, 2021 \/PRNewswire\/ &#8212; Gracell Biotechnologies Inc. (NASDAQ: GRCL) (&#8220;Gracell&#8221;), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies, today announced that it plans to release financial results for the fourth quarter and year ended December 31, 2020 after the close of the U.S. financial markets on Tuesday, March 9. Gracell&#8217;s management team plans to host a corresponding conference call beginning at 8:00 a.m. Eastern Time on Wednesday, March 10, to discuss the financial results and recent business developments. A replay of the webcast will be available on ir.gracellbio.comshortly after the conclusion of the event for 90 days. Conference call and webcast details: Wednesday, March 10, &hellip; Continue reading &quot;Gracell Biotechnologies to Report Fourth Quarter and Fiscal 2020 Financial Results on Tuesday, March 9, 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-23T13:03:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1358687\/gracell_logo_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Gracell Biotechnologies to Report Fourth Quarter and Fiscal 2020 Financial Results on Tuesday, March 9, 2021\",\"datePublished\":\"2021-02-23T13:03:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021\\\/\"},\"wordCount\":262,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1358687\\\/gracell_logo_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021\\\/\",\"name\":\"Gracell Biotechnologies to Report Fourth Quarter and Fiscal 2020 Financial Results on Tuesday, March 9, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1358687\\\/gracell_logo_Logo.jpg\",\"datePublished\":\"2021-02-23T13:03:45+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1358687\\\/gracell_logo_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1358687\\\/gracell_logo_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gracell Biotechnologies to Report Fourth Quarter and Fiscal 2020 Financial Results on Tuesday, March 9, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gracell Biotechnologies to Report Fourth Quarter and Fiscal 2020 Financial Results on Tuesday, March 9, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021\/","og_locale":"en_US","og_type":"article","og_title":"Gracell Biotechnologies to Report Fourth Quarter and Fiscal 2020 Financial Results on Tuesday, March 9, 2021 - Market Newsdesk","og_description":"PR Newswire SUZHOU and SHANGHAI, China, Feb. 23, 2021 \/PRNewswire\/ &#8212; Gracell Biotechnologies Inc. (NASDAQ: GRCL) (&#8220;Gracell&#8221;), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies, today announced that it plans to release financial results for the fourth quarter and year ended December 31, 2020 after the close of the U.S. financial markets on Tuesday, March 9. Gracell&#8217;s management team plans to host a corresponding conference call beginning at 8:00 a.m. Eastern Time on Wednesday, March 10, to discuss the financial results and recent business developments. A replay of the webcast will be available on ir.gracellbio.comshortly after the conclusion of the event for 90 days. Conference call and webcast details: Wednesday, March 10, &hellip; Continue reading \"Gracell Biotechnologies to Report Fourth Quarter and Fiscal 2020 Financial Results on Tuesday, March 9, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-02-23T13:03:45+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1358687\/gracell_logo_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Gracell Biotechnologies to Report Fourth Quarter and Fiscal 2020 Financial Results on Tuesday, March 9, 2021","datePublished":"2021-02-23T13:03:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021\/"},"wordCount":262,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1358687\/gracell_logo_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021\/","name":"Gracell Biotechnologies to Report Fourth Quarter and Fiscal 2020 Financial Results on Tuesday, March 9, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1358687\/gracell_logo_Logo.jpg","datePublished":"2021-02-23T13:03:45+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1358687\/gracell_logo_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1358687\/gracell_logo_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-tuesday-march-9-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Gracell Biotechnologies to Report Fourth Quarter and Fiscal 2020 Financial Results on Tuesday, March 9, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/441789","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=441789"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/441789\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=441789"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=441789"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=441789"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}